Vizgen
PrivateLast Round
Series E
Jan 8, 2026
Total Funding Raised
$328.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vizgen is a biotechnology company that provides spatially resolved, single-cell gene expression profiling tools to enhance understanding of biological systems and diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Imaging, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vizgen Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Vizgen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jan 8, 2026 | ||||
| Series D | Oct 9, 2024 | ||||
| Growth Equity | Mar 8, 2024 | ||||
| Series C | Jun 3, 2022 | ||||
| Series B | Jul 20, 2021 | ||||
Series B | Apr 7, 2021 |
Key People
Founding team and executive leadership
Vizgen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sofina | Series C |
| ARCH Venture Partners | Series B, Series D, Series C, Series A, Series E |
| M Ventures | Series D, Series E |
| Northpond Ventures | Series C, Series D, Series B, Series A, Series E |
| ARCH Venture Partners | Series B, Series D, Series C, Series A, Series E |
| Sofina S.A. | Series C |
| Blue Water Life Science Advisors | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
$48M Series E round completed.
- Nov 17, 2025
Collaboration with Ultivue to serve big pharma customers and CROs.
Vizgen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vizgen's valuation, stock price, and market status.